Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials in Baltimore, Maryland
6 recruitingBaltimore, Maryland
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca990 enrolled298 locationsNCT06883305
Recruiting
Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca990 enrolled268 locationsNCT06878261
Recruiting
Phase 2
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca1,160 enrolled363 locationsNCT07082738
Recruiting
Phase 2
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Chronic Obstructive Pulmonary Disease (COPD)Allergies
Johns Hopkins University334 enrolled23 locationsNCT07059091
Recruiting
Phase 3
Multi-Center Clean Air Randomized Controlled Trial in COPD
Chronic Obstructive Pulmonary Disease (COPD)
JHSPH Center for Clinical Trials770 enrolled11 locationsNCT06376994
Recruiting
Effectiveness of the WearME System for COPD Severity and Respiratory Function
Chronic Obstructive Pulmonary Disease (COPD)
LASARRUS Clinic and Research Center128 enrolled2 locationsNCT06751537